Sub-Saharan Africa's Plant Science Research Infrastructure Is Being Built on Donor Dependency — That Must Change

Sub-Saharan Africa sustains the food security of more than one billion people, yet the scientific infrastructure that underpins agricultural innovation across the region — plant breeding programs, genomics platforms, phenotyping facilities, genebanks, seed system research — is overwhelmingly financed not by the governments of the region but by external donors. This is not a peripheral observation about an inconvenient funding gap. It is the defining feature of SSA plant science, and it demands urgent and honest confrontation rather than the more comfortable narrative of partnership and capacity building under which the dependency is usually filed.

The distinction at the heart of this argument has to be precise. Donor support, time-limited and capacity-building in intent, is a legitimate instrument of international scientific cooperation. Donor dependency is different in kind: a self-perpetuating condition in which the continued functioning of national research systems requires external financing, in which research agendas are shaped by donor priorities rather than sovereign need, and in which the withdrawal of external funding would cause immediate institutional collapse. SSA plant science has crossed from the former into the latter. Agricultural R&D intensity across the region dropped from roughly 0.5% of agricultural GDP (AgGDP) in 2000 to 0.39% in 2016 — moving in the wrong direction even as the African Union's Maputo and Malabo Declarations committed member states to reaching 1%, with the trajectory corroborated by the ASTI Sub-Saharan Africa investment-trend series. Overall R&D expenditure across SSA sits at roughly 0.32–0.38% of GDP against a global average near 1.99%. Kenya's national agricultural research institute draws more than 66% of its budget from donor sources; in Tanzania, more than half of the national agricultural research system's revenue came from donors as recently as 2000, per KIT's stakeholder-funding analysis. These are not patches needed; they are fault lines.

The case has been stated explicitly by serious institutional voices. The Inter-Academy Partnership has written that "donor dependency must cease in agricultural research." The IDS Bulletin's landmark study, Plant Breeding in Sub-Saharan Africa in an Era of Donor Dependence, documented how programme performance itself has been distorted by the funding architecture. The African Integration Report 2025 warns that "the absence of predictable and autonomous funding mechanisms impedes the long-term viability of African-led responses." What remains unfinished is the reform agenda. This article maps the scale and geography of the dependency, dissects the five mechanisms by which it actively harms plant science, identifies the genuine building blocks of an endogenous alternative, proposes a five-pillar reform programme, and locates the entire argument in a geopolitical moment that makes action not merely advisable but existentially necessary.

Mapping the Dependency: Who Funds What, and How Much?

The funding architecture of SSA plant science is layered and interlocking. At the apex sit bilateral donors — USAID before its 2025 restructuring, the United Kingdom's FCDO, and the Bill & Melinda Gates Foundation — whose grant cycles and strategic priorities set the tempo of the entire system. Below them, multilateral institutions including the World Bank and the African Development Bank provide project-based capital. CGIAR centres (ICRISAT, CIMMYT, CIP, IITA, CIAT, and others) function simultaneously as funders, implementers, and de facto national research capacity for countries that lack their own. FARA, the Forum for Agricultural Research in Africa, was designed to provide continental coordination but remains itself subject to changing donor priorities and funding instability. The result is a system in which world-class science facilities "are not found elsewhere in Africa" inside CGIAR centres, while most national systems struggle to maintain basic laboratory equipment between grant cycles.

The aid envelope itself has shifted against agriculture. The share of official development assistance going to agriculture fell from 20.2% in 1983 to 5.7% in 2018, meaning that even within development finance, agriculture has been systematically deprioritised. The aggregate effect is that only 3% of global development funding reaches African farmers, against an estimated funding gap in African agriculture of roughly $200 billion.

AgGDP intensity figures from ASTI/IMF data; donor share estimates from AU and IFPRI sources. Cells marked “est.” reflect analytical inference from available data; figures are subject to country-year variation.

Country / Region	AgR&D / AgGDP	Donor share of AgR&D	Notable institutional features
SSA average	0.39% (2016)	~28–43%	Highly heterogeneous NARS; declining intensity ratio
Kenya	~0.5% (est.)	>66% (KARI)	Levy model partially operational; phenotyping and genomics gaps
Tanzania	Low (est.)	>50% (c. 2000)	Weak NARS; thin stable domestic funding base
Ethiopia	~0.20% AgGDP (2020)	~23% (down from 33% in 2016)	EIAR system; some domestic growth; infrastructure maintenance gap
Senegal	Low	High (ISRA)	ISRA agenda documented as skewed by donor priorities
Nigeria	Moderate	Lower (large domestic budget)	NRCRI: 6 research stations; technology-transfer and seed-system gaps
South Africa	~0.61–0.62% R&D / GDP	Low (largest domestic SSA budget)	DSI-funded phenomics; SAMRC genomics; sub-regional inequity
West Africa (CORAF zone)	Variable	High	CORAF/WECARD coordination role; shared infrastructure potential

The table reveals a pattern that aggregate statistics obscure: dependency is not uniform. South Africa and Nigeria are partial exceptions whose larger domestic budgets reduce external reliance, while most of the rest of the region remains deeply dependent. Ghana, Nigeria, and Senegal differ significantly in institutional capacity and donor dependence, which is analytically important: the variation demonstrates that the dependency is not an iron law of geography or income level but a policy outcome that can be changed.

The trend line is particularly alarming. Africa's gross R&D expenditure in absolute terms grew from approximately $22 billion to $37 billion between 2015 and 2023, but the intensity ratio for agricultural R&D has moved in the opposite direction. Agricultural output has grown faster than research investment. This is a systemic warning, not a success story. Outside some private-sector breeding for hybrid maize in East and Southern Africa, plant breeding remains essentially a public-sector activity, which means the decline in public investment is directly synonymous with the decline of the scientific enterprise itself.

The data themselves are part of the problem. The most recent year of standardised SSA agricultural R&D-intensity data is 2016, drawn from the ASTI series maintained by IFPRI under CGIAR. Nine years of post-pandemic, post-currency-shock, post-USAID-restructuring evidence is therefore absent from the central indicator on which the Malabo Biennial Review monitoring framework depends. Preliminary 2025 FAO–ASTI workshop materials suggest the gap has likely widened in countries such as Nigeria, where currency volatility and inflation have eroded the real value of agricultural R&D spending without showing up in the headline ratio. Reliance on external bodies for the basic statistical infrastructure of national accountability is itself a form of dependency, and the resulting data vacuum makes both the diagnosis above and the reform agenda below harder to operationalise.

It is worth converting the 1% commitment into a tractable absolute number. SSA agricultural GDP runs at roughly $300–350 billion annually on FAO and World Bank estimates, so the gap between current spending at 0.39% and the Malabo 1% commitment is on the order of $1.8–2.1 billion per year for the region as a whole. That figure is small compared with annual ODA flows, small compared with the AU's documented $1.43 trillion domestic-mobilisation potential, and a fraction of the cost of a single year of climate-driven yield losses across SSA. The reform is not unaffordable; it is unfunded.

The infrastructure gaps are most acute in the most capital-intensive domains. Africa lags significantly in implementing high-throughput field phenotyping due to funding constraints, and external donor funding is the primary mechanism by which what little capacity exists is sustained. ICRISAT's High Throughput Genotyping Services fills a gap most NARS cannot fill domestically. The BecA-ILRI Hub, established in Nairobi in 2003 as a shared continental biosciences facility, provides advanced laboratory access to African and international scientists; its core operational costs are funded through a partnership with the Bill & Melinda Gates Foundation. The region's most celebrated shared platforms remain externally anchored. ASTI has documented that "these advances will quickly be eroded with the withdrawal of donor funding if other funding sources are not secured."

Five Mechanisms of Harm: How Dependency Distorts Plant Science

The intellectual core of the argument is not that external funding is bad in itself. It is that entrenched dependency generates specific, identifiable mechanisms of harm that undermine the very scientific capacity it ostensibly supports. The five that follow are not a complete taxonomy, but they capture the dynamics most relevant to plant science specifically.

1. Agenda distortion and the erosion of research sovereignty

When donors fund research, they set its direction. This is not a conspiracy; it is an institutional logic. Donors answer to their own constituencies, parliamentary oversight bodies, and strategic frameworks, not to SSA farmers or governments. The result is systematic misalignment between research investment and agricultural need. A study of donor-funded research in SSA found that research agendas align with donor and corporate interests, with marginalised communities losing access to research on land rights and food sovereignty. R&D-related aid suffers chronically from "misalignment with national priorities and fragmentation across projects and donors, limiting research effectiveness." Senegal's ISRA provides a documented case study: its research agenda is "somewhat skewed toward goals that are not aligned with national priorities," and "the government leaves the funding of agricultural research to donors."

The most consequential expression of this distortion is the chronic underfunding of orphan crops. Sorghum, millet, and cowpea — alongside the indigenous leafy vegetables, tubers, and grains such as teff and enset that anchor smallholder diets across the continent — attract a fraction of the research investment devoted to globally traded commodities such as maize, wheat, and rice that interest donor constituencies. The African Orphan Crops Consortium and its African Plant Breeding Academy represent a genuine attempt to address this gap, having raised $6.5 million for the breeders' course. The Academy is itself, however, entirely donor-financed: a donor-funded solution to a donor-created problem. The growing formal seed sector in SSA, encouraged by AGRA and other donors, has generated controversy because the seed regulatory frameworks and IP regimes it promotes may not align with national agricultural policies or smallholder preferences. When donors drive not just research but the policy architecture around research, the sovereignty deficit deepens.

2. Institutional fragility and the project-ization of science

Donor funding arrives in discrete project cycles, typically three to five years. This temporal structure is fundamentally incompatible with the timescales of plant science. Developing a new crop variety from initial crosses to farmer-ready release requires a minimum of eight to twelve years of continuous work. Building a functional genomics platform requires sustained investment in equipment, bioinformatics capacity, consumables, and skilled personnel over a decade or more. Project-cycle financing cannot support either. The consequence is what we might call the project-ization of science: institutions become expert at writing proposals and closing reports rather than at conducting long-term research programmes.

The infrastructure consequences are well documented. Equipment purchased under donor grants frequently becomes non-functional after grant closure because maintenance budgets were absent from the original grant design and no domestic budget line covers them. This is not anecdote; it is a recurring feature of SSA laboratory infrastructure that has been repeatedly identified across health, agricultural, and environmental research systems. The same source notes that donor dependency "introduces a level of instability and uncertainty that can hinder the production of local infrastructures that build resilience."

Brain drain is the human-capital dimension of the same problem. Scientists trained under donor-funded programmes — often to doctoral and post-doctoral level — face a stark choice between staying in an institution whose funding is uncertain, whose equipment may be non-functional, and whose salary is tied to the next grant cycle, or migrating to institutions in the Global North or to CGIAR centres that offer stable salaries and career paths. The African Crop Improvement Academy has trained 117 African plant breeders and reports that brain drain has been reduced significantly through its programmes; the African Plant Breeders Association was formed specifically to reverse the trend. That such an organisation needed to be created at all is testimony to the severity of the underlying problem. A senior African scientist has publicly called for "global reparations to rebuild Africa's scientific capacity," framing brain drain not as individual choice but as systemic extraction.

3. Conditionality and policy distortion

Donor funding rarely arrives without conditions, explicit or implicit, regarding the institutional, regulatory, and technological frameworks within which funded research must operate. These conditions can include adoption of specific seed regulatory frameworks, intellectual property regimes, biosafety protocols, and technology platforms. When a government's agricultural research system is 60% or more donor-financed, its effective policy autonomy in these domains is severely constrained. The most documented case is the AGRA-linked push toward formal seed-sector development, which has been organised around the UPOV 1991 Convention framework for plant variety protection. Critics argue that variety registration requirements and seed certification systems modelled on UPOV/OECD frameworks undermine the informal seed systems that the majority of smallholder farmers actually rely upon. Whether or not one accepts that critique in full, the underlying dynamic is undeniable: donor financing shapes policy in ways that would not occur if governments were the primary funders.

4. The perverse suppression of domestic political will

The least visible mechanism may also be the most consequential. When donors reliably fill funding gaps, governments face reduced political pressure to increase domestic agricultural R&D budgets. The Malabo Declaration of 2014 committed AU member states to allocating 10% of national budgets to agriculture, a target that most have not met and that has never been extended with sufficient specificity to agricultural R&D intensity. The dynamic is self-reinforcing: donor dependency erodes the political accountability link between government and citizen that would otherwise generate pressure for domestic investment. As one analysis frames it, "donor dependency in much of Africa has broken the link of responsibility between government and citizen, making it too easy simply to blame donors for problems." Agricultural research contributes to productivity growth at an aggregate rate of return of 55%, a return that exceeds almost any alternative public investment, yet governments continue to underinvest precisely because the donor system obscures the cost of underinvestment.

Donor dependency in much of Africa has broken the link of responsibility between government and citizen, making it too easy simply to blame donors for problems.

5. Acute vulnerability to donor withdrawal

The preceding four mechanisms describe chronic, embedded harms. The fifth is acute: donor-dependent systems are existentially vulnerable to the sudden withdrawal of external financing. This is not a theoretical risk. Between 2022 and 2024, research funding to SSA declined by roughly 18% on the most recent published estimate, with East Africa experiencing particularly severe reductions and South Africa's NRF facing a 28% reduction over 2024–25. In 2025, official development assistance recorded its largest annual decline ever, falling by 23.1% according to OECD preliminary data released in April 2026. SSA countries now face a projected 16–28% decline in net funding as donor countries cut foreign assistance to prioritise domestic interests. African science programmes are already losing critical funding in climate research, research infrastructure, and scientist salaries as donor priorities shift.

The USAID restructuring of 2025 is not an isolated event but the leading edge of a broader contraction in global development finance. Climate-smart agricultural financing in SSA, already "based on donor funding which is mostly prohibitive due to high mainstreaming and upscaling costs," faces collapse in specific programme areas. CGIAR itself has acknowledged that its current funding model creates dependencies that undermine national ownership and that "funders and partner countries must commit to a funding model that empowers scientific excellence and strategic delivery." A system built on a foundation that is now visibly eroding cannot be described as anything other than fragile.

Climate change is a forcing function on the dependency, not a separate concern. Adapting SSA cropping systems to projected mid-century warming, rainfall variability, and emerging pest pressure will require continuous, multi-decade selection programmes — precisely the timescale that project-cycle financing cannot support. The longer the dependency persists, the larger the climate-adaptation backlog grows, and the more expensive the eventual transition becomes. Climate is therefore not just one more reason to reform the financing model; it is a clock running against it.

What Is Already Being Built: Promising Endogenous Models

Intellectual honesty requires acknowledging what is working, and identifying the genuine building blocks of a post-dependency architecture. The point is not to provide false comfort but to demonstrate that the transition is feasible, and to ground the reform agenda in mechanisms that are already partially proven rather than in policy fantasy.

The African BioGenome Project (AfBP) is the most ambitious endogenous initiative in African plant genomics. The project aims to sequence approximately 105,000 non-human genomes including plants, animals, fungi, and other eukaryotes as part of a pan-continental effort to unlock the African bioeconomy. The African Plant Genome Assembly and Annotation Fellowship (2025) is building local capacity in plant genomics across the continent. The installation of Africa's first MGI T7 Sequencer at the SAMRC Genomics Platform — operating as a not-for-profit facility to make cutting-edge sequencing available to African researchers for large-scale projects — marks a concrete infrastructure milestone. Locally led genomics projects are beginning to shape a new model for research as the continent advances toward sequencing its biodiversity. Honesty requires acknowledging the tension: AfBP remains substantially dependent on international partnerships and external financing. It is a model in transition, not yet a model of self-sufficiency.

Levy-based research financing is the most mature alternative financing mechanism currently available at scale. Kenya's experience with commodity levies — in which a fraction of value from export or domestic crop sales is channelled into a national research fund — demonstrates that industry can become a sustainable co-financier of applied plant science. KARI's 66% donor dependency is precisely the problem that levy-model extension is designed to address. The KIT stakeholder-driven funding analysis documents how levy systems can reduce per-country dependency when properly designed and governed. The model is not without limitations: it tends to concentrate research investment in commercially significant export crops, potentially deepening the orphan-crop problem. As a complement to domestic public investment, however, it is proven.

Domestic resource mobilisation is the macro-level counterpart. Africa has demonstrated the capacity to mobilise domestic resources for development priorities; health and education financing has grown substantially through domestic channels, and the AfDB has documented the mechanisms that made this possible. An African Union analysis demonstrates that Africa could mobilise an additional $1.43 trillion in domestic resources, a figure that contextualises the agricultural R&D gap not as a resource-scarcity problem but as a political-priority problem. Sovereign wealth funds, agricultural development banks, and national science foundations are all potential vehicles for channelling domestic capital into plant science.

Regional research-infrastructure integration offers a path to reducing per-country costs while building genuine African ownership. CORAF/WECARD, ASARECA, and SACAU provide the institutional architecture for pooling resources across sub-regions. The 9th International Plant Phenotyping Symposium (IPPS9), to be co-hosted in Africa in 2026, signals growing continental engagement with precision phenotyping infrastructure. A model of one high-throughput phenotyping platform per sub-region, shared by five to eight countries and funded through regional levies or AU budget allocations, would be both technically feasible and economically rational.

University–industry linkages are emerging in Nigeria, Ghana, and South Africa, where universities are developing plant-science programmes with private-sector co-investment. South Africa's Department of Science and Innovation is funding plant phenomics capacity that will expand high-tech plant phenotyping capabilities and foster innovation in plant breeding. The limitation is real: private-sector interest in plant-science R&D in SSA remains thin outside large agribusiness, and the crops of greatest commercial interest to industry are not always the crops of greatest importance to food security.

Translational research with commercial sustainability potential is illustrated by the ICGEB biofertiliser commercialisation project, which focuses on developing VH Biofertiliser for smallholder farmers in SSA facing declining soil fertility. The commercial pathway creates a potential revenue stream that could partially self-finance future research. The project remains externally anchored, but the model is instructive.

The Reform Agenda: What Must Actually Change

The building blocks described above do not, individually or collectively, constitute a solution. A coherent reform agenda requires five reinforcing pillars, each addressing a distinct dimension of the underlying problem.

Pillar I: Domestic public investment as a non-negotiable sovereign commitment

Governments must treat agricultural R&D intensity as a sovereign policy target, not a donor-supplemented aspiration. The 1% AgGDP target established by the Malabo Declaration is a minimum floor, not a ceiling. Countries currently investing 0.2–0.3% of AgGDP — and several SSA countries fall below even 0.20% — should commit to reaching 0.6% within five years and 1% within ten years, with annual parliamentary reporting on progress. Finance ministries must ring-fence agricultural R&D allocations from austerity cycles, using the same constitutional or legislative protection mechanisms that some countries have applied to health spending. The political argument is straightforward: agricultural research generates a documented aggregate rate of return of 55%, a figure that should command the attention of any finance minister.

The critical institutional reform is to decouple national research-system budgets from donor grant cycles. Governments must establish permanent, domestically funded budget lines for NARS operations, salaries, and infrastructure maintenance — even if those lines begin small. A NARS that can guarantee salary continuity independent of donor funding retains scientists. One that cannot, does not.

Pillar I must also engage the constraint under which most SSA finance ministries currently operate: IMF programmes that limit discretionary fiscal expansion. The constraint is real, but the response need not be "find more money." A debt-for-science swap, structured analogously to the debt-for-nature swaps now operational in Belize, Seychelles, and Ecuador, would let creditors agree to redirect a portion of interest payments into a ring-fenced domestic AgR&D fund managed by an independent board with parliamentary oversight. The instrument re-prioritises existing flows under fiscal constraint rather than adding new external commitments. It also has political-economy benefits absent from straight grant aid: the discipline of using existing debt-service capacity creates a domestic accountability link that grants do not.

Pillar II: Diversify the financing architecture

Commodity levy systems should be expanded and formalised across SSA. Every major crop value chain — whether export-oriented or domestically focused — should contribute a fraction of revenue to a national plant-science research fund. The design must explicitly include orphan crops and subsistence-oriented value chains, using cross-subsidisation from high-value export commodities where necessary.

The political economy of levies is the unspoken obstacle to scaling them. Commodity boards — Kenya's Tea Board, Côte d'Ivoire's Conseil du Café-Cacao, Ethiopia's Coffee and Tea Authority — will resist diversion of levy revenue from their own commercially significant value chains toward orphan crops, and that resistance is not unreasonable. A workable design is a 1-for-1 matching model: the government provides a tax credit or matching contribution equal to the commodity-board contribution, conditional on a defined fraction (proposed at 20–30%) flowing into a central Food Security Fund earmarked for non-commercial crops such as cowpea, finger millet, sorghum, and indigenous leafy vegetables. Cross-subsidy becomes a positive-sum bargain rather than a contested redistribution, and orphan-crop research gains a recurrent revenue stream that is not subject to donor cycle risk.

Beyond levies, three underexplored financing instruments deserve serious treatment. The first is diaspora science bonds. African diaspora communities represent a substantial and largely untapped source of capital with deep interest in the continent's development; science-specific bonds, structured with transparent governance and impact reporting, could channel diaspora capital into research infrastructure. The instrument is not hypothetical: Israel has issued diaspora bonds since 1951 to finance national priorities, and Ethiopia's Grand Renaissance Dam diaspora bond programme demonstrated that the model functions in the African policy environment, even where execution and returns have been imperfect. Plant science, however, is invisible infrastructure: a regional seed bank or a phenotyping platform does not generate the same diaspora attention as a megastructure on the Nile, and the trust deficit is acute. To absorb diaspora capital at meaningful scale, science bonds will need to be managed by independent foundations with clear governance — entities such as the Science for Africa Foundation rather than direct national treasuries — so that contributors can verify that funds are not absorbed into general budget support. The model functions only if the diaspora can audit it. The second is philanthropic capital from African high-net-worth individuals and foundations, currently almost entirely absent from agricultural R&D financing in stark contrast to its growing role in health and education. The third is structured public–private partnerships with seed companies, agrochemical firms, and food processors that benefit directly from plant-science advances, formalised through co-investment frameworks with clear IP-sharing arrangements.

Pillar III: Reform the donor relationship — from dependency to partnership

The argument is not for the end of international scientific cooperation but for its fundamental restructuring. Donors should shift from project-based to programmatic, long-term institutional support — commitments of ten to fifteen years that allow genuine capacity building, career-path development, and infrastructure investment. The Gates Open Research framework on promoting sustainability of supranational agricultural R&D provides a template for how this transition can be structured.

Donors should explicitly support the development of domestic financing mechanisms rather than substituting for them. A donor that funds a research project while simultaneously crowding out domestic political will to fund the same research is not a development partner; it is a dependency enabler. Donor compacts should include explicit sunset clauses: binding, time-limited commitments to transition specific programmes from donor-financed to domestically-financed over defined periods, with milestone-based accountability.

The CGIAR system requires particular attention. Despite all efforts to increase African ownership of the supranational agricultural research agenda, high donor dependency remains a factor that limits such ownership. CGIAR's acknowledged need to broaden its donor base and diversify funding must be paired with a genuine commitment to building NARS capacity to the point where national systems can eventually absorb and lead the research functions that CGIAR currently performs on their behalf.

The current One CGIAR restructuring poses a specific risk that the general "African ownership" framing does not capture: integration is not the same as centralisation, and the latter is not what NARS need. Centralisation under a single global research architecture risks reducing national systems to service providers for global research hubs — implementing rather than setting the agenda, generating data rather than holding the IP, hosting the field sites rather than running them. The reform ask is precise. Every regional CGIAR laboratory or platform should be required to publish, at the time of establishment, a binding ten-year exit strategy specifying the conditions, capacity benchmarks, and handover timeline under which it transitions to national or regional African ownership. Without such a clause, integration becomes permanent dependency by another name.

Pillar IV: Build sovereign research infrastructure — not just human capital

The tendency to invest donor funds in training and human capital while neglecting physical infrastructure is a documented pattern with predictable consequences: trained scientists return to non-functional laboratories and leave. Physical infrastructure — phenotyping platforms, genomics facilities, seed banks, bioinformatics computing infrastructure, cold-chain systems — must be owned, operated, and maintained by African institutions, not by CGIAR centres or international NGOs.

Two specific reforms are immediately actionable. The first is maintenance endowments: every capital grant for research equipment should be paired with an endowment fund sufficient to cover consumables and maintenance for a minimum of ten years. This is a simple design change that donors could implement immediately at modest additional cost. The second is regional shared infrastructure: a model of one high-throughput phenotyping platform per sub-region, shared by five to eight countries and governed by a regional body, would bring advanced phenotyping capacity within reach of countries that could never afford it individually. The 2026 IPPS9 co-hosting in Africa creates an opportunity to catalyse exactly this kind of regional platform commitment.

Pillar V: Reorient research agendas toward African food-system priorities

NARS must develop their own strategic research agendas through genuine stakeholder consultation — with farmers, processors, consumers, and local governments, not just donors and international scientists. This is not a procedural nicety; it is the mechanism by which research investment becomes connected to food-system outcomes.

Orphan crops, agroecological research, climate adaptation for SSA-specific agroecological zones, and the integration of indigenous knowledge into formal breeding programmes must receive proportional investment. Development finance currently dominates agroecological transition funding in Kenya, forming approximately 50% of the total, meaning that even the most locally relevant research agendas remain externally financed. African scientists must lead publication, IP ownership, and technology transfer from research conducted on African crops, in African environments, for African farmers. The current model — in which African institutions provide field sites, germplasm access, and local knowledge while northern institutions lead publications and hold IP — is extractive, and must end.

A donor that funds a research project while simultaneously crowding out domestic political will to fund the same research is not a development partner; it is a dependency enabler.

The Geopolitical Moment: Why This Argument Is More Urgent Than Ever

Three scenarios converge in 2026 to make the argument for structural reform not merely academically compelling but existentially necessary.

Scenario A — The aid contraction accelerates

The 2025 USAID restructuring is the most visible manifestation of a broad contraction in global development finance. Multiple OECD donors are reducing ODA, redirecting funds toward domestic priorities, and questioning the return on decades of development investment. SSA plant-science systems that have not built domestic financing resilience by the time this contraction fully materialises will not merely stagnate; they will collapse. Programmes that took twenty years to build can be dismantled in a single budget cycle. The window for managed transition is closing.

Scenario B — The AI and genomics revolution bypasses Africa

The next decade of plant science will be defined by AI-assisted breeding, high-throughput genomics, precision phenotyping, and large-scale genomic data integration. These technologies require sustained, large-scale investment in infrastructure, data systems, and computational capacity. The African BioGenome Project's ambition to sequence approximately 105,000 African genomes is precisely the kind of initiative that positions the continent to participate in this revolution rather than merely consume its outputs. Participation requires data sovereignty — control over who generates, owns, and accesses African plant genomic data — and that sovereignty cannot be guaranteed under a donor-dependent model. The intersection of plant-science infrastructure, data governance, and the Nagoya Protocol on access and benefit sharing will define whether Africa becomes a producer or a consumer of the genomics revolution. The Nagoya framework, ratified in 2014 under the Convention on Biological Diversity, places jurisdiction over access to genetic resources with provider countries — but the rules apply only to the use of physical samples, not to the digital sequence information increasingly extracted from them. The unresolved status of digital sequence information under Nagoya is the specific legal locus where Africa's claim to genomic sovereignty will be tested over the next five years.

Scenario C — Food sovereignty as a geopolitical asset

As climate change intensifies and global food systems come under stress, SSA's agricultural biodiversity — its wild crop relatives, its landrace varieties, its agroecological knowledge systems — becomes strategically significant. Countries that build sovereign plant-science capacity now will be positioned to leverage this value on their own terms. Those that remain dependent will find their agricultural futures shaped by external actors, whether traditional Western donors, Chinese agricultural-investment partnerships, or multinational seed companies. Chinese agricultural investment in SSA is growing rapidly, including in research partnerships, creating both an alternative financing opportunity and a risk of substituting one form of dependency for another. African governments must engage these dynamics strategically, not reactively.

Scenario D — The Chinese alternative is not a solution

Chinese agricultural engagement in SSA has expanded rapidly since the 2018 Forum on China-Africa Cooperation (FOCAC) Beijing Declaration, including roughly two dozen Agricultural Technology Demonstration Centres operating across the continent and a steady increase in research partnerships between Chinese and African institutions. The scale is meaningful, and the timing — coinciding with the contraction in OECD ODA — makes Chinese capital an increasingly visible alternative source of finance for African plant-science programmes. The strategic question is whether engagement with this alternative replaces the pathology of donor dependency or merely changes its address. The Chinese model favours bilateral arrangements, government-to-government technology transfer, and tied commercial interests through Chinese seed and agrochemical firms; the structural risk is that it substitutes UPOV-aligned conditionality with a different set of constraints on policy autonomy. The argument here is not against Chinese engagement, which African governments have every right to pursue. It is that the same five-pillar framework — sovereign commitment, diversified financing, sunset clauses, sovereign infrastructure, sovereign agendas — must apply to Chinese partnerships as rigorously as to Western ones. Substituting one form of dependency for another does not reduce the dependency.

The convergence of the four scenarios shifts the debate. The Science for Africa Foundation's 2025 annual update documents African science programmes already losing critical funding as donor priorities shift. The question is no longer whether the current model is sustainable — it demonstrably is not — but whether the transition to a domestically anchored model will be managed and deliberate, or chaotic and destructive.

Explore Further

Three analytical directions extend the argument of this article without repeating it.

1. Comparative political economy of research-financing transitions. Brazil's EMBRAPA, South Korea's rural development institutes, and India's ICAR all successfully transitioned from externally dependent to domestically led agricultural research systems over periods of two to three decades. The political-economy conditions that enabled these transitions — land reform, commodity export booms, state-led industrial policy, strategic use of international partnerships — deserve systematic comparative analysis in SSA contexts. Which of these enabling conditions are present or replicable in specific SSA countries? Which are absent, and what substitutes might serve the same function?

2. Data sovereignty in African plant genomics. As the African BioGenome Project and related initiatives generate plant-genomic data at continental scale, fundamental questions of ownership, access, and benefit-sharing remain unresolved. Who controls the data generated from African crop wild relatives? How do national access and benefit-sharing frameworks under the Nagoya Protocol interact with open-science norms in genomics? What institutional architecture — at national, regional, and continental levels — is needed to ensure that Africa's genomic wealth generates African scientific and economic benefit? These questions are not peripheral to plant-science infrastructure; they are its emerging frontier.

3. Fiscal-space modelling for agricultural R&D investment. This article argues that the 1% AgGDP target is achievable but does not deliver the country-by-country financial roadmap that would make the argument fully operational. A rigorous fiscal-space analysis examining tax-revenue trends, commodity-export revenues, potential levy-system yields, and competing budget pressures in ten to fifteen SSA countries would provide the concrete financial architecture that policymakers need. Such an analysis would also identify which countries have the fiscal capacity to move fastest, creating a sequenced implementation agenda rather than an undifferentiated call for action.

The path from dependency to sovereignty in SSA plant science is neither short nor simple. It is, however, navigable. The cost of not navigating it — measured in crop failures, food insecurity, and scientific marginalisation — is far higher than the cost of the transition itself. The reform agenda set out above is not a wishlist. It is the minimum coherent response to an embedded problem that has been visible for two decades and has now begun to break under the pressure of a donor contraction nobody on the African side chose.

Frequently Asked Questions

Short answers grounded in the article's argument and primary sources.

What is the difference between donor support and donor dependency?

Donor support is time-limited, transitional, capacity-building external financing offered as a complement to a domestically funded research base. Donor dependency is a self-perpetuating structural condition in which the continued functioning of national research systems requires external financing, in which research agendas are shaped by donor priorities rather than sovereign need, and in which the withdrawal of external funding would cause immediate institutional collapse. SSA plant science has crossed from the former into the latter.

How donor-dependent is SSA agricultural research, in numbers?

Agricultural R&D intensity across SSA fell from approximately 0.5% of agricultural GDP in 2000 to 0.39% in 2016, against a 1% target set by the AU Maputo and Malabo Declarations. Country-level dependency varies sharply: Kenya's KARI draws more than 66% of its budget from donors, Tanzania's national agricultural research system was over 50% donor-funded around 2000, and Senegal's ISRA agenda is documented as skewed toward goals that are not aligned with national priorities.

What are the five mechanisms by which donor dependency harms plant science?

First, agenda distortion: research priorities reflect donor and corporate interests rather than national or smallholder need. Second, institutional fragility from project-cycle financing that cannot match the eight-to-twelve-year timescales of plant breeding. Third, conditionality embedded in donor financing that constrains policy autonomy on seed, IP, and biosafety. Fourth, the perverse suppression of domestic political will to fund research because donors fill the gap. Fifth, acute vulnerability to donor withdrawal — visible in the 2025 ODA contraction.

Is the African BioGenome Project a successful example of endogenous African plant science?

It is the most ambitious endogenous plant-genomics initiative in Africa, aiming to sequence approximately 105,000 non-human genomes including African crop wild relatives, landraces, and biodiversity. Locally led genomics projects under the AfBP umbrella are reshaping the research model. Intellectual honesty requires acknowledging that AfBP remains substantially dependent on international partnerships and external financing today; it is a model in transition rather than a model of self-sufficiency.

What would a domestically anchored alternative look like in practice?

Five reinforcing pillars. First, treat the 1% AgGDP target as a sovereign commitment with parliamentary reporting, ring-fenced from austerity. Second, diversify financing through commodity levies, diaspora science bonds, African philanthropic capital, and structured public-private partnerships. Third, restructure donor relationships toward 10–15 year programmatic support with explicit sunset clauses. Fourth, build sovereign research infrastructure paired with maintenance endowments and regional shared platforms. Fifth, reorient research agendas toward orphan crops, agroecology, and SSA-specific climate adaptation.

Why is this argument urgent in 2026?

Three converging pressures. The 2025 USAID restructuring marks the leading edge of a broader contraction in global development finance, with ODA falling roughly 23% in 2025. SSA countries face a projected 16–28% decline in net development funding. The next decade of plant science will be defined by AI-assisted breeding, high-throughput genomics, and precision phenotyping that require sustained, large-scale investment. SSA's agricultural biodiversity is a strategic asset whose value will be captured by sovereign systems or extracted by external actors.

For citation

Cite this article

APA Chicago BibTeX

Kumar, A. (2026, April 30). Sub-Saharan Africa's Plant Science Research Infrastructure Is Being Built on Donor Dependency — That Must Change. the-opinions.com. https://the-opinions.com/articles/03-sub-saharan-africa-donor-dependency.htmlCopy

Kumar, Abhinandan. "Sub-Saharan Africa's Plant Science Research Infrastructure Is Being Built on Donor Dependency — That Must Change." the-opinions.com, April 30, 2026. https://the-opinions.com/articles/03-sub-saharan-africa-donor-dependency.html.Copy

@article{kumar2026ssa, author = {Kumar, Abhinandan}, title = {Sub-{Saharan} {Africa}'s Plant Science Research Infrastructure Is Being Built on Donor Dependency --- That Must Change}, journal = {the-opinions.com}, year = {2026}, month = apr, day = {30}, url = {https://the-opinions.com/articles/03-sub-saharan-africa-donor-dependency.html} }Copy

Continue reading

← Previous

Elevated CO₂ Does Not Uniformly Benefit Crop Yields, and the Fertilization Narrative That Claims Otherwise Has a Funded Lineage and a Measurable Policy Cost

Climate & Plant Systems · 22 min read

Next →

Science Journalists Are Not Equipped to Cover Plant Biotechnology — Here Is the Evidence

Science Communication · 17 min read

Correspondence

Responses

This article is open for response. If you'd like to weigh in — with a counter-argument, a citation I missed, a domain perspective from your own NARS, CGIAR centre, donor agency, or African research institution — write to [email protected] with the subject “Response to Article 03.” The strongest responses, with permission, will be appended here a week or two after publication.

A note on these publications

Opinion, not impartial reportage. Articles published on the-opinions.com are argued positions grounded in the cited literature. They are not peer-reviewed research, syndicated reporting, or official statements of any institution. Where a debate is contested, this article takes a side and defends it; readers seeking a survey of every position should treat the references as a starting point and consult the linked primary sources directly.

AI-assisted drafting. Articles on this site are researched, drafted, and edited with AI assistance under human authorial direction. The author selects the question, structures the argument, vets sources, makes the final editorial calls, and takes responsibility for what is published. AI is used as a research and drafting tool, not as a substitute for editorial judgement.

No financial or institutional conflict. The author has no financial relationship with any of the donors, multilateral institutions, CGIAR centres, NARS, foundations, agribusinesses, or African research institutions discussed in this article, nor with any organisation that might benefit from the policy positions argued here. Views are personal and do not represent any employer or affiliate.

Sources and errata. All substantive claims are linked to primary sources inline; the full reference list appears above this disclaimer. If a source has been misread, a number is incorrect, or a position has been misstated, please write to [email protected]. Substantive corrections will be appended publicly to the article with a dated note.